Functional Blockade of Small GTPase RAN Inhibits Glioblastoma Cell Viability.
Ontology highlight
ABSTRACT: Glioblastoma, the most common malignant tumor in the brain, lacks effective treatments and is currently incurable. To identify novel drug targets for this deadly cancer, the publicly available results of RNA interference screens from the Project Achilles database were analyzed. Ten candidate genes were identified as survival genes in 15 glioblastoma cell lines. RAN, member RAS oncogene family (RAN) was expressed in glioblastoma at the highest level among all candidates based upon cDNA microarray data. However, Kaplan-Meier survival analysis did not show any correlation between RAN mRNA levels and patient survival. Because RAN is a small GTPase that regulates nuclear transport controlled by karyopherin subunit beta 1 (KPNB1), RAN was further analyzed together with KPNB1. Indeed, GBM patient
SUBMITTER: Sheng KL
PROVIDER: S-EPMC6331428 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA